State Ledger
Company profile

Boundless Bio, Inc. CIK 1782303

Ticker
BOLD (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
La Jolla, CA 92037
Fiscal year end
2025 (FY)
Market Data
Close
$2.52
Change
-$0.04
Change %
-1.56%
Volume
3,056

BOLD · trading date Oct 12, 2026 · previous close $2.56 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$58.20M
Total assets
$157.06M
Total liabilities
$58.41M
Stockholders' equity
$98.65M
Cash & equivalents
$17.87M
Operating income
-$63.55M
Operating cash flow
-$46.66M
Capital expenditures
$546.0K

Fiscal year 2025, via 10-K filed 2026-03-09. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$47.21M
Free cash flow margin
—
Liabilities / assets
37.2%
Equity / assets
62.8%
CapEx / revenue
—
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$58.20M $157.06M $58.41M $98.65M
2024 — -$65.36M $206.41M $55.77M $150.64M
2023 — -$49.43M $129.89M $9.36M -$127.08M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 425
2026-08-28
Financials filed via
Form 10-K
filed 2026-03-09

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
La Jolla, CA 92037
11099 NORTH TORREY PINES ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:19 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to California — Public Companies